Early results of obesity surgery;Wczesne wyniki chirurgicznego leczenia otyłości

Diabetologia Polska

Volumn 10, Issue 2, 2003, Pages 246-253

  Strzelczyk, Janusz ^a,b   Czupryniak, Leszek ^a   Pawłowski, Maciej ^a   Szymański, Dariusz ^a   Nowicki, Michał ^a   Gaszyński, Tomasz ^a   Woźniak Sosnowska, Urszula ^a   Wasiak, Janusz ^a   Loba, Jerzy ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Klin Chir Ogolnej i Transplant   (Poland)

Author keywords

Gastric by pass surgery; Insulin resistance; Metabolic syndrome; Obesity

Indexed keywords

CHOLESTEROL; GLUCOSE; POLYPROPYLENE; TRIACYLGLYCEROL;

ABDOMINAL WALL; ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HERNIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLISM; MORBID OBESITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; SAFETY; STOMACH BYPASS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING; WEIGHT REDUCTION;

EID: 0348142218     PISSN: 12334723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Saryusz-Wolska M., Czupryniak L., Ruxer J., Drzewoski J. Wystȩpowanie cukrzycy, otyłości i zaburzeń lipidowych w populacji mieszkańców dzielnicy Łó dź Śródmieście - badania w ramach Narodowego Programu Zwalczania Cukrzycy. Diabetol. Pol., 2001, 8, 102.
2. Pi-Sunyer P.F. The medical risks of obesity. Obes. Surg., 2002, 12, Suppl 1: 6S-11S.
3. Ravussin E., Swinburn B.A. Pathophysiology of obesity. Lancet, 1992, 340, 404-84
4. Deitel M. Increasing prevalence of obesity as a cause of cancer. Obes. Surg., 2001, 11, 123-4.
5. Wadden TA. Treatment of obesity by very low calorie diet, behaviour therapy and their combination: a five year perspective, Int. J. Obes., 1989, 13, suppl 2, 39.
6. Deitel M., Shikora S.A. The development of the surgical treatment of morbid obesity. J. Am. Coll. Nutr., 2002, 21, 365-71.
7. Strzelczyk J. Współczesne metody chirurgicznego leczenia otyłości. Diabetol. Pol., 2001, 8, 204-13.
8. Gastrointestinal surgery for severe obesity NIH consensus development conference. Nutrition, 1996, 12, 397-404.
9. Alberti K.G.M.M., Heurtier A. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1 - diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med., 1998, 15, 539-53.
10. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F. Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985, 28, 412-9
11. National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), Report. 2001. Str. II-40-41.
12. Wilson P.W., D'Agostino RB., Levy D., Beianger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation, 1998, 97, 976-84.
13. Mason E.E., Ito C. Gastric bypass. Ann. Surg., 1969, 170, 329-39.
14. Watala C. Biostatystyka - wykorzystanie metod statystycznych w pracy badawczej w naukach biomedycznych. (-medica press, Bielsko-Biala, 2002.
15. Armitage P., Berry G., Matthews J.N.S. Statistical Methods in Medical Research. Blackwell Science, Oksford, 2002.
16. Czupryniak L., Strzelczyk J., Loba J. Effect of Gastric By-Pass Surgery on 24-Hour Blood Pressure Variation and Plasma insulin in Morbidly Obese Patients. Diabetes, 2002, 51, A351.
17. Astrup A., Grunwald G.K., Melanson E.L., Saris W.H., Hill J.O. The rote of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies. Int. J. Obes. Relat. Metab. Disord., 2000, 24, 1545-52.
18. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp. Diabetes Care, 1999, 22, 1462-70.
19. Reaven G.M. Insulin resistance/compensatory hyperinsulinemia, essential hypertension and cardiovascular disease. J. Clin. Endocrinol. Metab., 2003, 88, 2399-403.
20. Wong N.D., Sciammarella M.G., Polk D., Gallagher A., Miranda Peats I., Whitcomb B., Hamachovitz R., Friedman J.D., Hayes S., Berman DS. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J. Am. Coll. Cardiol., 2003, 41, 1547-53.
21. Lakka H.M., Laaksonnen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., Salonen J.T. The metabolic syndrome and total and cardiovascular disease mortality in middle aged men. JAMA, 2002, 288, 2709-16.
22. Wolf A.M., Kortner B., Kuhlman H.W. Results of bariatric surgery. Int. J. Obes. Relat. Metabol. Disord., 2001, 25 suppl 1, 113-4.
23. Pories W.J., Swanson M.S., MacDonald K.G. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann. Surg., 1995, 222, 339-50.
24. Brolin R.E., Bradley L.E., Wilson D.C., Cody R.P. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J. Gastrointest. Surg., 2000, 4, 464-9.
25. Despres J.P. Dyslipidaemia and obesity. Baillere's Clin. Endocrin. Metabol., 1994, 8, 629-60.
26. Nadel I., Cypryk K., Pertyrński T., Sobczuk A., Stetkiewicz T. Wystȩpowanie schorzeń z zespolu metabolicznego u kobiet w wieku pomenopauzalnym w regionie łódzkim. Pol. Arch. Med. Wewn., 2001, 106, 823-8.
27. Dixon J., O'Brien P.E. Lipid profile in the severely obese - changes with the weight after lap-band surgery. Obes. Surg., 2002, 10, 903-10.
28. Luyckx F.H., Scheen A.J., Desaive C., Dewe W., Gielen J.E., Lefebvre RJ. Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes Metab., 1998, 24, 355-61.
29. Samaha F.F., Iqbal N., Seshadri P., Chicano K.L., Daily D.A., McGrory J., Williams T., Williams M., Gracely E.J., Stern L. A low carbohydrate as compared with low fat diet in severe obesity. N. Engl. J. Med., 2003, 348, 2057-8.
30. Gaw A. HDL-C and triglyceride levels- relationship to coronary heart disease and treatment with statins. Cardiovasc. Drugs Ther., 2003, 17, 53-62.
31. Farmer J.A., Gotto A.M. Jr. The Heart Protection Study - expanding the boundaries for high-risk coronary disease prevention. Am. J. Cardiol., 2003, 92 (1A), 3i-9i.
32. Reeder B.A., Angel A., Ledoux M., Rabkin S.W., Young T.K., Sweet L.E. Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ, 1992, 146, 2009-19.
33. Short K.R., Vittone J.L., Bigelow M.L., Proctor D.N., Rizza R.A., Coenen Schimke J.M., Nair K.S. Impact of aerobic exercise training on age related changes in insulin sensitivity and muscle oxidative capacity. Diabetes, 2003, 52, 1888-96.
34. Tatoń J. Struktura tkanki tluszczowej i regulacja ilości tluszczu w ustroju. W: Tatoń J. Otyłość - patofizjologia, diagnostyka, leczenie. PZWL Warszawa, 1985, 67-84.
35. Meigs J.B. The metabolic syndrome. Br. Med. J., 2003, 327, 61-2.
36. Polyzogopoulou E.V., Klfarentzos F., Vagenakis A.G., Alexandrides T.K. Restoration of normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes, 2003, 52 1098-103.
37. Reaven G.M. Role of insulin resistance in human disease. Diabetes, 1988, 37, 1595-607.
38. Wȩgierko J. Znaczenie praktyczne podzialu cukrzycy na poszczególne jej postacie. Pol. Arch. Med. Wewn., 1955, 25, 791-7.
39. Tatoń J. Rzeczywiste i pozorne zwia̧zki pomiȩdzy otyłośia̧ i cukrzyca̧ niezależna̧ od insuliny i niektórymi innymi zaburzeniami - wnioski terapeutyczne. Pol. Tyg. Lek., 1993, 48, suppl 1, 42-47.
40. Talbert R.L. Role of the National Cholesterol Educational Program Adult Treatment Panel III guidelines in managing dyslipidemia. Am. J. Health Sys. Pharm., 2003, 60, suppl 2, 3-8.
41. Aguilar-Salinas C.A., Rojas R., Gomez-Perez F.J., Valles V., Rios-Torres J.M., Franco A., Olaiz G., Rull J.A., Sepulveda J. Analysis of the agreement between World Health Organisation criteria and the National Cholesterol Educational Program III definition of the metabolic syndrome - results from a population-based study. Diabetes Care, 2003, 26, 1635.
42. Czupryniak L., Pawłowski M., Saryusz-Wolska M., Ruxer J., Loba J. Specifying prevention targets in metabolic syndrome - are its elements equally prevalent in urban population? Diabetes & Metabolism, 2003, 29, 4S62.